Eton Pharmaceutcials
ETON
31 hedge funds and large institutions have $24.2M invested in Eton Pharmaceutcials in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 8 closing their positions.
985% more call options, than puts
Call options by funds: $1.61M | Put options by funds: $148K
0% more capital invested
Capital invested by funds: $24.1M → $24.2M (+$78.7K)
0.19% more ownership
Funds ownership: 23.29% → 23.48% (+0.19%)
3% less funds holding
Funds holding: 32 → 31 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$487K |
| 2 |
FCBT
First Citizens Bank & Trust
Raleigh,
North Carolina
|
+$393K |
| 3 |
JP Morgan Chase
New York
|
+$95.5K |
| 4 |
PP
PDT Partners
New York
|
+$92.1K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$86.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$395K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$166K |
| 3 |
AIC
AWM Investment Company
New York
|
-$108K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$89.1K |
| 5 |
Millennium Management
New York
|
-$89K |
ETON Hedge Fund Activity: Q1 2022 in Review
31 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q1 2022, worth a combined $24.2M — up 0.33% from $24.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ETON and 7 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 7 added.
The largest buyer was Westside Investment Management, adding an estimated $487K. The largest seller was Marshall Wace, exiting entirely with an estimated $395K sold.
- 31 institutional investors held Eton Pharmaceutcials (ETON) as of Q1 2022, down from 32 in Q4 2021.
- Funds reported $24.2M of Eton Pharmaceutcials stock for Q1 2022, up 0.33% quarter-over-quarter.
- 7 funds opened new Eton Pharmaceutcials positions in Q1 2022 and 8 closed out, a net change of -1 holder.
- The largest Eton Pharmaceutcials buyer in Q1 2022 was Westside Investment Management, an estimated $487K added.
- The largest Eton Pharmaceutcials seller in Q1 2022 was Marshall Wace, an estimated $395K sold.
Based on aggregated 13F filings for Q1 2022.